Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
CVRx, Inc. announced that Devoted Health, a major Medicare Advantage insurer, has established a coverage policy for its Barostim therapy, effective July 2026. This policy complements existing coverage from Humana and CMS approvals, covering a significant portion of Medicare Advantage members and supporting broader patient access to this FDA-approve…
Aureus Greenway Holdings Inc. (Nasdaq: PUSA) and Powerus have announced the start of manufacturing Guardian counter-UAS interceptors in the Gulf Cooperation Council region through a partnership with a local defense manufacturer. This regional manufacturing is designed to speed delivery of U.S.-designed defense systems to allies facing drone threats…
La Rosa Holdings Corp., a US-based real estate and PropTech company, announced first half 2026 financial results marked by a nearly 10% increase in gross profit to $3.7 million and a 42% reduction in operating loss to $4.2 million compared to the prior year. The company also reported a 25% decrease in operating expenses and a 9.4% improvement in ne…
Lexicon Pharmaceuticals has earned its third $10 million milestone payment in 2026 from Novo Nordisk following successful patient dosing in the Phase 1 trial of LX9851, a novel oral small molecule for obesity and metabolic disorders. This achievement brings total milestone payments to $75 million out of a potential $1 billion collaboration deal. Th…
BioCardia, a leader in cellular therapeutics for cardiovascular diseases, announced FDA confirmation of Pre-Submission Meeting minutes for its Helix Transendocardial Delivery Catheter. This ratification supports BioCardia's planned follow-on pre-submission intended to enable Helix's approval via the De Novo regulatory pathway, potentially accelerat…
Our Bond, Inc., a New York-based international company specializing in AI-powered Preventative Personal Security, announced a live investor webinar hosted by CEO Doron Kempel to discuss recent developments and the company's accelerating momentum. The company operates globally, serving more than 1.25 million security service requests with presence i…
Prenetics has converted early R&D and genomics credibility into a direct-to-consumer consumer health engine with IM8. A $1 billion growth financing led by General Catalyst's CVF, a $70 million cash injection from the Insighta sale, zero debt and $171.1 million in adjusted liquidity create a rare combination: aggressive marketing capacity with a cle…
Harmony Gold (HMY) is a core gold exposure with a growing copper footprint and attractive cashflow characteristics as gold prices stay elevated. At $23.54 and a $14.8B market cap, the stock shows bullish technicals and improving liquidity. Reaffirm Buy with a clear entry at $23.54, stop at $19.00 and primary target at $29.00, horizon mid-term (45 t…
Expion Energy, Inc. (Nasdaq: XPON) announced the acquisition of oil and gas exploration assets in Eastern Louisiana, marking its entry into the oil and gas sector as part of an expanded operating strategy. The company appointed Kevin Sellers as new CEO to lead this platform expansion, and rebranded from Expion360 Inc. to better align with its broad…
Alpha Modus Holdings, Inc. (NASDAQ: AMOD) announced a strategic consulting and business development agreement with Circle The Wagons, Inc. to accelerate deployment of its AI-powered retail platform ARIA and financial service Alpha Cash in the fragmented US independent grocery market, valued at $353 billion. The collaboration aims to rapidly move fr…
Royal Gold has leaned into growth while keeping leverage minimal. At $261 today, the company offers diversified exposure to gold, silver and copper without mine-level execution risk. With a market cap near $22B, low debt, steady EPS, and dividend growth, RGLD is a tactical long for investors who want leverage to metals with an income kicker and dow…
Amarin Corporation plc announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2026 featuring new analyses from the REDUCE-IT trial and mechanistic EPA data. These presentations cover treatment adherence, long-term outcomes, and biomarker insights related to cardiovascular risk reduction with icosapent ethyl (VASCEPA/V…
Generac (GNRC) has shifted from a cyclical residential story toward commercial and industrial and data-center power solutions. Recent results and a large hyperscaler supply deal have reignited revenue growth and earnings beats. Valuation is not cheap, but improving fundamentals and supportive technicals set up a mid-term swing trade with defined ri…
The optical equipment group that outperformed earlier this year has reversed course sharply. Names including Coherent, Corning, Ciena and Lumentum have moved materially off their 52-week highs after hefty YTD gains driven by AI datacenter fiber demand. Technical indicators are bearish, fair value models still show premium valuations even after the …
Deutsche Post DHL (ticker DPDGY) has shifted from a legacy postal utility to a higher-quality logistics platform. Operational improvements, disciplined pricing in parcel markets, and network investments justify paying up relative to the old business. This trade targets a near-term entry and a multi-horizon upside while balancing execution and macro…
Edible Garden AG, a Nasdaq-listed leader in controlled environment agriculture, announced a strategic partnership with Square Roots to develop a new generation of clean-label, functional ready-to-drink beverages. Combining Square Roots' expertise in plant science with Edible Garden's advanced Farm-to-Formula® platform and aseptic manufacturing, the…
Biogen and Eisai announced US availability of LEQEMBI IQLIK®, a subcutaneous autoinjector for initiation and maintenance therapy of early Alzheimer's disease, offering a more convenient and flexible alternative to intravenous infusion. The treatment, supported by robust clinical trial data demonstrating slowed disease progression and significant co…
Clearmind Medicine Inc., a clinical-stage biotech focused on psychedelic-derived neuroplastogens, announced the U.S. publication of a patent application covering a novel combination of MDMA and N-acylethanolamines such as PEA, aimed at treating PTSD, anxiety, and eating disorders. This comes alongside the FDA's newly finalized guidance for clinical…
Rhythm Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare has approved IMCIVREE® (setmelanotide) to treat patients with acquired hypothalamic obesity (HO), a rare disease characterized by significant weight gain due to hypothalamic injury. Supported by positive Phase 3 trial data, this marks IMCIVREE as the first approved…
Evolution Metals & Technologies Corp. (Nasdaq: EMAT), a U.S.-based critical materials and manufacturing company, announced its preliminary inclusion in FTSE Russell's Russell 3000® and Russell 2000® indexes, effective September 21, 2026, pending final review. This inclusion is anticipated to increase the company's visibility among institutional and…
ASML Holding N.V., a global leader in semiconductor equipment manufacturing, has disclosed recent transactions under its ongoing share buyback program announced in January 2026. Over five consecutive days in August, ASML repurchased a total of approximately 252,684 shares at weighted average prices ranging from €1,506.98 to €1,618.13 per share. The…
Elicio Therapeutics announced its management will participate in one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference to discuss its development of next-generation immunotherapies for KRAS-driven cancers. The company focuses on off-the-shelf immunotherapy candidates, aiming to improve treatment for solid tumors driven by KRAS, B…
Humacyte, Inc. announced that following favorable discussions with the FDA, it intends to file a supplemental Biologics License Application (BLA) in November 2026 to expand approval of its acellular tissue engineered vessel (ATEV) for dialysis access. This follows FDA approval of ATEV for vascular trauma in 2024. The application will be supported b…
Bionano Genomics, a Nasdaq-listed biotechnology company specializing in genome analysis solutions, announced that its management will present and hold one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The presentation will showcase the company’s advancements in optical genome mapping technolo…
AEON Biopharma, listed on NYSE American as AEON, has named Paul Lee, M.D., Ph.D., former Deputy Director at the FDA's Office of Neuroscience, as acting Chief Regulatory Officer. Dr. Lee, who has been advising AEON on regulatory strategy via Clintrex Research LLC, will now lead the company’s interactions with the FDA and oversee the regulatory roadm…
